Kasvu Therapeutics Closes €30 Million Series A Round
Kasvu Therapeutics has raised €30 million in Series A financing, one of the larger early-stage biotech commitments announced via GlobeNewswire this cycle.
Topic
Kasvu Therapeutics
Topic
Topic
Topic
Kasvu Therapeutics has raised €30 million in Series A financing, one of the larger early-stage biotech commitments announced via GlobeNewswire this cycle.